Optimark and Cad - a phase IV clinical study of FDA data

Summary:

Cad is reported as a side effect among people who take Optimark (gadoversetamide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Omniscan, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Cad when taking Optimark. It is created by eHealthMe based on reports of 3,054 people who have side effects when taking Optimark from the FDA, and is updated regularly.

What is Optimark?

Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.

What is Cad?

Cad is found to be associated with 1,446 drugs and 2,154 conditions by eHealthMe. Check the latest studies of Cad.

On Apr, 26, 2026

3,054 people reported to have side effects when taking Optimark.
Among them, 24 people (0.79%) have Cad.

Among these 24 people:

How long have people been on Optimark when they have Cad? *

What is the gender of people who have Cad when taking Optimark? *

female: 26.09 %
male: 73.91 %

What is the age of people who have Cad when taking Optimark? *

What are other drugs people take besides Optimark? *

What are other side effects people have besides Cad? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 21 people, 87.50%
Cardiac Failure Congestive: 12 people, 50.00%
Chest Pain: 11 people, 45.83%
Carotid Artery Stenosis (narrowing of carotid artery): 9 people, 37.50%
Acute Myocardial Infarction (acute heart attack): 8 people, 33.33%
Nausea And Vomiting: 8 people, 33.33%
Dyspnea (difficult or laboured breathing): 8 people, 33.33%
Pulmonary Oedema (fluid accumulation in the lungs): 8 people, 33.33%
Weakness: 7 people, 29.17%
Neuropathy Peripheral (surface nerve damage): 7 people, 29.17%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 10 people, 41.67%
High Blood Pressure: 5 people, 20.83%
High Blood Cholesterol: 4 people, 16.67%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 12.50%
Depression: 3 people, 12.50%
Cardiac Disorder: 3 people, 12.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.33%
Ventricular Dysfunction (heart dysfunction): 1 person, 4.17%
Sleep Disorder: 1 person, 4.17%
Muscle Aches (muscle pain): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Optimark and have Cad?

- Check whether Cad is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Optimark:

Optimark (3,055 reports)

Cad treatments and more:

Cad (70,507 reports)

Browse all side effects of Optimark:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cad:

Cad (1,446 drugs)

Browse all the conditions that are associated with Cad:

Cad (2,154 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadoversetamide (the active ingredients of Optimark) and Optimark (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.